Clinical significance of CD8‐positive lymphocytes on tumor cell clusters of ascites cell block in ovarian high‐grade serous carcinoma

Abstract Background The clinical significance of CD8‐positive (CD8+) lymphocytes on tumor cell clusters of ascites cell blocks in patients with ovarian high‐grade serous carcinoma (HGSC) was investigated. Methods Among HGSC patients who underwent surgery from January 2014 to December 2019, 38 patien...

Full description

Bibliographic Details
Main Authors: Hideki Iwahashi, Morikazu Miyamoto, Tsubasa Ito, Jin Suminokura, Taira Hada, Hiroki Ishibashi, Soichiro Kakimoto, Hiroko Matsuura, Rie Suzuki, Shinya Minabe, Susumu Matsukuma, Hitoshi Tsuda, Masashi Takano
Format: Article
Language:English
Published: Wiley 2022-05-01
Series:Cancer Medicine
Subjects:
Online Access:https://doi.org/10.1002/cam4.4592
_version_ 1817987462598754304
author Hideki Iwahashi
Morikazu Miyamoto
Tsubasa Ito
Jin Suminokura
Taira Hada
Hiroki Ishibashi
Soichiro Kakimoto
Hiroko Matsuura
Rie Suzuki
Shinya Minabe
Susumu Matsukuma
Hitoshi Tsuda
Masashi Takano
author_facet Hideki Iwahashi
Morikazu Miyamoto
Tsubasa Ito
Jin Suminokura
Taira Hada
Hiroki Ishibashi
Soichiro Kakimoto
Hiroko Matsuura
Rie Suzuki
Shinya Minabe
Susumu Matsukuma
Hitoshi Tsuda
Masashi Takano
author_sort Hideki Iwahashi
collection DOAJ
description Abstract Background The clinical significance of CD8‐positive (CD8+) lymphocytes on tumor cell clusters of ascites cell blocks in patients with ovarian high‐grade serous carcinoma (HGSC) was investigated. Methods Among HGSC patients who underwent surgery from January 2014 to December 2019, 38 patients with ascites cell block were selected. Using these cell blocks and primary ovarian tumor tissue, the presence of CD8+ lymphocytes and the expression of PD‐L1 were examined immunohistochemically. Tumor cell clusters were defined as cell clumps consisting of more than 10 malignant cells in cell block. Cases with at least one CD8+ lymphocyte in tumor cell cluster were defined as positive CD8+ lymphocytes (Group A); others were defined as negative CD8+ lymphocytes (Group B). The tumor tissue CD8+ lymphocytes were counted mechanically. Clinicopathological features were retrospectively compared between the two groups. Results In total, 38 cases were identified: 25 (65.8%) in Group A and 13 (34.2%) in Group B. More cases in Group A were positive for CD4 (p < 0.01), PD‐L1 (p = 0.02), FoxP3 (p = 0.02) and had a higher number of CD8+ lymphocytes in the tissue (p = 0.03). Patients in Group A had better progression‐free survival (p < 0.01) and overall survival (p = 0.04). In multivariate analysis, Group A was an independent prognostic factor for both progression‐free survival (hazard ratio, 0.24; p < 0.01) and overall survival (hazard ratio, 0.21; p = 0.03). Conclusion The presence of CD8+ lymphocytes in tumor cell clusters of ascites was associated with the status of immune reaction in the tissue and prognosis in patients with HGSC and might be useful information of the immune‐associated therapy.
first_indexed 2024-04-14T00:22:44Z
format Article
id doaj.art-52046819e42b45cba87658aeb2afe6e3
institution Directory Open Access Journal
issn 2045-7634
language English
last_indexed 2024-04-14T00:22:44Z
publishDate 2022-05-01
publisher Wiley
record_format Article
series Cancer Medicine
spelling doaj.art-52046819e42b45cba87658aeb2afe6e32022-12-22T02:22:54ZengWileyCancer Medicine2045-76342022-05-0111102085209510.1002/cam4.4592Clinical significance of CD8‐positive lymphocytes on tumor cell clusters of ascites cell block in ovarian high‐grade serous carcinomaHideki Iwahashi0Morikazu Miyamoto1Tsubasa Ito2Jin Suminokura3Taira Hada4Hiroki Ishibashi5Soichiro Kakimoto6Hiroko Matsuura7Rie Suzuki8Shinya Minabe9Susumu Matsukuma10Hitoshi Tsuda11Masashi Takano12Department of Obstetrics and Gynecology National Defense Medical College Hospital Tokorozawa JapanDepartment of Obstetrics and Gynecology National Defense Medical College Hospital Tokorozawa JapanDepartment of Obstetrics and Gynecology National Defense Medical College Hospital Tokorozawa JapanDepartment of Obstetrics and Gynecology National Defense Medical College Hospital Tokorozawa JapanDepartment of Obstetrics and Gynecology National Defense Medical College Hospital Tokorozawa JapanDepartment of Obstetrics and Gynecology National Defense Medical College Hospital Tokorozawa JapanDepartment of Obstetrics and Gynecology National Defense Medical College Hospital Tokorozawa JapanDepartment of Obstetrics and Gynecology National Defense Medical College Hospital Tokorozawa JapanDepartment of Obstetrics and Gynecology National Defense Medical College Hospital Tokorozawa JapanDepartment of Laboratory Medicine National Defense Medical College Hospital Tokorozawa JapanDepartment of Laboratory Medicine National Defense Medical College Hospital Tokorozawa JapanDepartment of Basic Pathology National Defense Medical College Hospital Tokorozawa JapanDepartment of Obstetrics and Gynecology National Defense Medical College Hospital Tokorozawa JapanAbstract Background The clinical significance of CD8‐positive (CD8+) lymphocytes on tumor cell clusters of ascites cell blocks in patients with ovarian high‐grade serous carcinoma (HGSC) was investigated. Methods Among HGSC patients who underwent surgery from January 2014 to December 2019, 38 patients with ascites cell block were selected. Using these cell blocks and primary ovarian tumor tissue, the presence of CD8+ lymphocytes and the expression of PD‐L1 were examined immunohistochemically. Tumor cell clusters were defined as cell clumps consisting of more than 10 malignant cells in cell block. Cases with at least one CD8+ lymphocyte in tumor cell cluster were defined as positive CD8+ lymphocytes (Group A); others were defined as negative CD8+ lymphocytes (Group B). The tumor tissue CD8+ lymphocytes were counted mechanically. Clinicopathological features were retrospectively compared between the two groups. Results In total, 38 cases were identified: 25 (65.8%) in Group A and 13 (34.2%) in Group B. More cases in Group A were positive for CD4 (p < 0.01), PD‐L1 (p = 0.02), FoxP3 (p = 0.02) and had a higher number of CD8+ lymphocytes in the tissue (p = 0.03). Patients in Group A had better progression‐free survival (p < 0.01) and overall survival (p = 0.04). In multivariate analysis, Group A was an independent prognostic factor for both progression‐free survival (hazard ratio, 0.24; p < 0.01) and overall survival (hazard ratio, 0.21; p = 0.03). Conclusion The presence of CD8+ lymphocytes in tumor cell clusters of ascites was associated with the status of immune reaction in the tissue and prognosis in patients with HGSC and might be useful information of the immune‐associated therapy.https://doi.org/10.1002/cam4.4592ascites cell blockCD8‐positive lymphocyteshigh‐grade serous carcinomahybrid cell countimmunohistochemical staining
spellingShingle Hideki Iwahashi
Morikazu Miyamoto
Tsubasa Ito
Jin Suminokura
Taira Hada
Hiroki Ishibashi
Soichiro Kakimoto
Hiroko Matsuura
Rie Suzuki
Shinya Minabe
Susumu Matsukuma
Hitoshi Tsuda
Masashi Takano
Clinical significance of CD8‐positive lymphocytes on tumor cell clusters of ascites cell block in ovarian high‐grade serous carcinoma
Cancer Medicine
ascites cell block
CD8‐positive lymphocytes
high‐grade serous carcinoma
hybrid cell count
immunohistochemical staining
title Clinical significance of CD8‐positive lymphocytes on tumor cell clusters of ascites cell block in ovarian high‐grade serous carcinoma
title_full Clinical significance of CD8‐positive lymphocytes on tumor cell clusters of ascites cell block in ovarian high‐grade serous carcinoma
title_fullStr Clinical significance of CD8‐positive lymphocytes on tumor cell clusters of ascites cell block in ovarian high‐grade serous carcinoma
title_full_unstemmed Clinical significance of CD8‐positive lymphocytes on tumor cell clusters of ascites cell block in ovarian high‐grade serous carcinoma
title_short Clinical significance of CD8‐positive lymphocytes on tumor cell clusters of ascites cell block in ovarian high‐grade serous carcinoma
title_sort clinical significance of cd8 positive lymphocytes on tumor cell clusters of ascites cell block in ovarian high grade serous carcinoma
topic ascites cell block
CD8‐positive lymphocytes
high‐grade serous carcinoma
hybrid cell count
immunohistochemical staining
url https://doi.org/10.1002/cam4.4592
work_keys_str_mv AT hidekiiwahashi clinicalsignificanceofcd8positivelymphocytesontumorcellclustersofascitescellblockinovarianhighgradeserouscarcinoma
AT morikazumiyamoto clinicalsignificanceofcd8positivelymphocytesontumorcellclustersofascitescellblockinovarianhighgradeserouscarcinoma
AT tsubasaito clinicalsignificanceofcd8positivelymphocytesontumorcellclustersofascitescellblockinovarianhighgradeserouscarcinoma
AT jinsuminokura clinicalsignificanceofcd8positivelymphocytesontumorcellclustersofascitescellblockinovarianhighgradeserouscarcinoma
AT tairahada clinicalsignificanceofcd8positivelymphocytesontumorcellclustersofascitescellblockinovarianhighgradeserouscarcinoma
AT hirokiishibashi clinicalsignificanceofcd8positivelymphocytesontumorcellclustersofascitescellblockinovarianhighgradeserouscarcinoma
AT soichirokakimoto clinicalsignificanceofcd8positivelymphocytesontumorcellclustersofascitescellblockinovarianhighgradeserouscarcinoma
AT hirokomatsuura clinicalsignificanceofcd8positivelymphocytesontumorcellclustersofascitescellblockinovarianhighgradeserouscarcinoma
AT riesuzuki clinicalsignificanceofcd8positivelymphocytesontumorcellclustersofascitescellblockinovarianhighgradeserouscarcinoma
AT shinyaminabe clinicalsignificanceofcd8positivelymphocytesontumorcellclustersofascitescellblockinovarianhighgradeserouscarcinoma
AT susumumatsukuma clinicalsignificanceofcd8positivelymphocytesontumorcellclustersofascitescellblockinovarianhighgradeserouscarcinoma
AT hitoshitsuda clinicalsignificanceofcd8positivelymphocytesontumorcellclustersofascitescellblockinovarianhighgradeserouscarcinoma
AT masashitakano clinicalsignificanceofcd8positivelymphocytesontumorcellclustersofascitescellblockinovarianhighgradeserouscarcinoma